REPLICEL LIFE SCIENCES INC. — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2022)

-CA$743.2K

Total Assets (FY2022)

CA$798.2K

Total Equity (FY2022)

-CA$5.9M

Cash Flows from Operating Activities (FY2022)

-CA$1.4M

Source: REPLICEL LIFE SCIENCES INC. 20-F filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.